NCT02354274Recruiting
Novel Approach to Radiotherapy in Locally Advanced Lung Cancer Concomitant Navelbine®
Novel Approach to Radiotherapy in Locally Advanced Lung Cancer - Heterogeneous FDG-guided Dose Escalation With Concomitant Navelbine®
Source: ClinicalTrials.gov · Last updated 25 Apr 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To investigate the effect of escalation of radiation dose to tumor and lymph nodes based on an inhomogeneous dose distribution controlled by FDG-PET positive areas compared to a standard homogeneous dose spread
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 330 (estimated)
- First submitted
- 19 Jan 2015
- Start date
- Jan 2015
- Primary completion date
- Oct 2029
- Lead sponsor
- Olfred Hansen
- Diseases
- Lung cancer
- NCT number
- NCT02354274
What you commit to
- Study type: Interventional
- Planned participants: 330
- From Jan 2015 to the primary completion date, Oct 2029
- 7 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Former thoracic radiotherapy, unless there is no significant overlap with previous fields
- Unable to take oral medications or needing intravenous nutrition
Other illness
- Any unstable systemic disorder (including infection , unstable angina, congestive heart failure , severe liver , kidney or metabolic disease)
- Any other active malignant disease
- Ulcer
Other
- Need for nasal oxygen
- Nursing women
Who the study is looking for
- Patients with histologically or cytologically proven locally advanced NSCLC stage IIB to IIIB
- Performance status 0-1
- Able to comply with treatment and follow study and follow-up procedures
- Women must have negative pregnancy test
- Signed, informed consent
- Plan for radiotherapy with conventional 66 Gy/ 33 F, which meets all dosing limits two normal tissue must be available
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (7)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Aalborg University Hospital Coordinator of this site? Confirm its status | Aalborg | Denmark | Not yet recruiting |
| Aarhus University Hospital Coordinator of this site? Confirm its status | Aarhus | Denmark | Recruiting |
| Rigshospitalet Coordinator of this site? Confirm its status | Copenhagen | Denmark | Not yet recruiting |
| Herlev University Hospital Coordinator of this site? Confirm its status | Herlev | Denmark | Recruiting |
| Department of Oncology, Naestved Hospital Coordinator of this site? Confirm its status | Næstved | Denmark | Not yet recruiting |
| Department of Oncology, Odense University Hospital Coordinator of this site? Confirm its status | Odense | Denmark | Recruiting |
| Department of Oncology, Vejle Hospital Coordinator of this site? Confirm its status | Vejle | Denmark | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.